DWA
CYTK icon

Dorsey Wright & Associates’s Cytokinetics CYTK Stock Holding History

Dorsey Wright & Associates’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-712
Closed -$17K – 318
2020
Q2 		$17K Hold
712
– – ﹤0.01% 174
2020
Q1 		$8K Buy
+712
New +$9.08K ﹤0.01% 183
2019
Q4 		– Sell
-876
Closed -$10K – 286
2019
Q3 		$10K Buy
+876
New +$11K ﹤0.01% 251

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Dorsey Wright & Associates's CYTK Position: Q3 2020 in Review

Dorsey Wright & Associates sold out of Cytokinetics (CYTK) in Q3 2020, closing a stake of 712 shares — an estimated $17K sold.

Dorsey Wright & Associates first reported a position in CYTK in Q3 2019 and held it in 3 quarters. The position peaked at $17K in Q2 2020. 181 funds tracked by Wall St. Rank hold CYTK as of Q3 2020.

  • Dorsey Wright & Associates reported no remaining Cytokinetics position as of Q3 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 712 Cytokinetics shares in Q3 2020, an estimated $17K.
  • Dorsey Wright & Associates first reported a position in Cytokinetics in Q3 2019 and held it in 3 quarters.
  • Dorsey Wright & Associates's Cytokinetics position peaked at $17K in Q2 2020.
  • 181 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2020.

Based on Dorsey Wright & Associates's 13F filing for Q3 2020, filed 28 Oct 2020.